Rhythm Pharmaceuticals (RYTM)
(Delayed Data from NSDQ)
$49.28 USD
+0.19 (0.39%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $49.78 +0.50 (1.01%) 4:46 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.81 |
EPS Last Quarter | -0.55 |
Last EPS Surprise | 21.43% |
ABR | 1.38 |
Earnings ESP
|
30.00% |
---|---|
Current Year | -4.44 |
Next Year | -2.75 |
EPS (TTM) | -4.36 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 32.20M | 35.56M | 122.80M | 182.23M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 33.60M | 39.09M | 127.21M | 218.96M |
Low Estimate | 30.00M | 32.30M | 117.34M | 154.62M |
Year ago Sales | 22.50M | 24.23M | 77.43M | 122.80M |
Year over Year Growth Est. | 43.09% | 46.76% | 58.60% | 48.40% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.81 | -0.72 | -4.44 | -2.75 |
# of Estimates | 7 | 6 | 7 | 7 |
Most Recent Consensus | -0.57 | -0.58 | -4.02 | -2.05 |
High Estimate | -0.57 | -0.55 | -4.02 | -2.05 |
Low Estimate | -1.23 | -0.88 | -4.66 | -3.57 |
Year ago EPS | -0.76 | -0.70 | -3.20 | -4.44 |
Year over Year Growth Est. | -6.58% | -2.86% | -38.75% | 38.03% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 2 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 3 | 4 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.81 | -0.72 | -4.44 | -2.75 |
7 Days Ago | -0.81 | -0.72 | -4.44 | -2.75 |
30 Days Ago | -0.80 | -0.70 | -4.40 | -2.64 |
60 Days Ago | -0.76 | -0.67 | -4.45 | -2.44 |
90 Days Ago | -0.77 | -0.66 | -4.44 | -2.43 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.57 | -0.58 | -4.02 | -2.05 |
Zacks Consensus Estimate | -0.81 | -0.72 | -4.44 | -2.75 |
Earnings ESP | 30.00% | 18.88% | 9.37% | 25.38% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.55 | -2.35 | -0.70 | -0.76 | NA |
Estimate | -0.70 | -2.34 | -0.70 | -0.76 | NA |
Difference | 0.15 | -0.01 | 0.00 | 0.00 | 0.04 |
Surprise | 21.43% | -0.43% | 0.00% | 0.00% | 5.25% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more